(Q45858485)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Marcella Franquesa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Marcella Franquesa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Herrero-Fresneda I

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Torras J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Cruzado JM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Lloberas N

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Fillat C

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Grinyó JM

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

17 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

265-274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001510

21 January 2020

exact match

0 references

cites work

A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Mechanisms of myofibroblast activity and phenotypic modulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Ameliorative effect of hepatocyte growth factor on glycerol-induced acute renal failure with acute tubular necrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Mice body weight gain is prevented after naked human leptin cDNA transfer into skeletal muscle by electroporation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Non-viral gene transfer of murine spleen cells achieved by in vivo electroporation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Intramuscular SP1017-formulated DNA electrotransfer enhances transgene expression and distributes hHGF to different rat tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

DNA electrotransfer: its principles and an updated review of its therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Reduction of postischemic immune inflammatory response: an effective strategy for attenuating chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Living kidney donors and hypoxia-inducible factor-1??

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Hepatocyte growth factor in renal disease: cause or cure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Stimulation of hepatocyte growth factor in human acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

The natural history of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Early protocol renal allograft biopsies and graft outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001510

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16710352%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 January 2020

1033643137

0 references

1 reference